Sectors
DMAA
Drugs Made In America Acquisition Corp.
10.75
5 x 10.65
5 x 10.54
bid
ask
+
0.00
0.00%
5 @ 04:00 PM
10.75 +0.00 (0.00%)
| Ytd | 3.66% | |
| 1y | 4.88% |
10.74
day range
10.75
10.23
52 week range
10.76
| Open | 10.75 | Prev Close | 10.75 | Low | 10.74 | High | 10.75 | Mkt Cap | 260.98M |
| Vol | 4.13K | Avg Vol | 29.27K | EPS | 0.18 | P/E | 59.72 | Forward P/E | N/A |
| Beta | 0.01 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-20 | 50-d Avg | 10.69 | 200-d Avg | 10.52 | 1yr Est | 0.00 |
DMAA News
benzinga.com
Drugs Made in America Acquisition Corp. Signs LOI For $1B De-SPAC Deal With Power Analytics Global
On April 7, 2026, Drugs Made in America Acquisition Corp. (the "Company") entered into a let
defenseworld.net
Drugs Made In America Acquisition Corp. $DMAA Shares Sold by DLD Asset Management LP
DLD Asset Management LP reduced its stake in Drugs Made In America Acquisition Corp. (NASDAQ: DMAA)